Lombard Odier Asset Management (USA)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,500
Closed -$2.56M 386
2022
Q2
$2.56M Buy
+10,500
New +$2.57M 0.1% 153
2015
Q4
Sell
-20,000
Closed -$2.77M 156
2015
Q3
$2.77M Buy
+20,000
New +$3.15M 0.24% 126

Other funds holding AMGN

Lombard Odier Asset Management (USA)'s AMGN Position: Q3 2022 in Review

Lombard Odier Asset Management (USA) sold out of Amgen (AMGN) in Q3 2022, closing a stake of 10,500 shares — an estimated $2.56M sold.

Lombard Odier Asset Management (USA) first reported a position in AMGN in Q3 2015 and held it in 2 quarters. The position peaked at $2.77M in Q3 2015. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

  • Lombard Odier Asset Management (USA) reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 10,500 Amgen shares in Q3 2022, an estimated $2.56M.
  • Lombard Odier Asset Management (USA) first reported a position in Amgen in Q3 2015 and held it in 2 quarters.
  • Lombard Odier Asset Management (USA)'s Amgen position peaked at $2.77M in Q3 2015.
  • 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2022, filed 14 Nov 2022.